1. Home
  2. BMRN vs RBRK Comparison

BMRN vs RBRK Comparison

Compare BMRN & RBRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BMRN
  • RBRK
  • Stock Information
  • Founded
  • BMRN 1996
  • RBRK 2013
  • Country
  • BMRN United States
  • RBRK United States
  • Employees
  • BMRN N/A
  • RBRK N/A
  • Industry
  • BMRN Biotechnology: Pharmaceutical Preparations
  • RBRK
  • Sector
  • BMRN Health Care
  • RBRK
  • Exchange
  • BMRN Nasdaq
  • RBRK NYSE
  • Market Cap
  • BMRN 12.1B
  • RBRK 14.2B
  • IPO Year
  • BMRN 1999
  • RBRK 2024
  • Fundamental
  • Price
  • BMRN $55.00
  • RBRK $85.49
  • Analyst Decision
  • BMRN Buy
  • RBRK Buy
  • Analyst Count
  • BMRN 22
  • RBRK 19
  • Target Price
  • BMRN $93.43
  • RBRK $98.59
  • AVG Volume (30 Days)
  • BMRN 2.2M
  • RBRK 4.3M
  • Earning Date
  • BMRN 08-04-2025
  • RBRK 06-05-2025
  • Dividend Yield
  • BMRN N/A
  • RBRK N/A
  • EPS Growth
  • BMRN 152.82
  • RBRK N/A
  • EPS
  • BMRN 2.71
  • RBRK N/A
  • Revenue
  • BMRN $2,950,227,000.00
  • RBRK $977,710,000.00
  • Revenue This Year
  • BMRN $12.23
  • RBRK $36.37
  • Revenue Next Year
  • BMRN $9.99
  • RBRK $24.48
  • P/E Ratio
  • BMRN $20.29
  • RBRK N/A
  • Revenue Growth
  • BMRN 19.36
  • RBRK 43.89
  • 52 Week Low
  • BMRN $52.93
  • RBRK $28.34
  • 52 Week High
  • BMRN $94.85
  • RBRK $103.00
  • Technical
  • Relative Strength Index (RSI)
  • BMRN 35.12
  • RBRK N/A
  • Support Level
  • BMRN $54.46
  • RBRK N/A
  • Resistance Level
  • BMRN $58.17
  • RBRK N/A
  • Average True Range (ATR)
  • BMRN 1.39
  • RBRK 0.00
  • MACD
  • BMRN -0.04
  • RBRK 0.00
  • Stochastic Oscillator
  • BMRN 13.08
  • RBRK 0.00

About BMRN BioMarin Pharmaceutical Inc.

BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments aimed at addressing complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria (PKU), hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development.

About RBRK RUBRIK INC

Rubrik Inc is a company that offers data security solutions to organizations ranging from the largest companies world-wide to mid-sized smaller customers. Its platform is architected to help organizations achieve cyber resilience, which encompasses cyber posture and cyber recovery. It enables organizations to confidently accelerate digital transformation and leverage the cloud to realize business agility. Geographically, the company operates in the Americas, EMEA (Europe, the Middle East, and Africa) and APAC (Asia Pacific). It generates maximum revenue from Americas.

Share on Social Networks: